Abraham Ceesay

2017 - scPharmaceuticals

In 2017, Abraham Ceesay earned a total compensation of $726.9K as Chief Operating Officer at scPharmaceuticals, a 22% decrease compared to previous year.

Compensation breakdown

Bonus$147,460
Non-Equity Incentive Plan$19,300
Option Awards$187,676
Salary$369,944
Other$2,509
Total$726,889

Ceesay received $369.9K in salary, accounting for 51% of the total pay in 2017.

Ceesay also received $147.5K in bonus, $19.3K in non-equity incentive plan, $187.7K in option awards and $2.5K in other compensation.

Rankings

In 2017, Abraham Ceesay's compensation ranked 10,439th out of 14,666 executives tracked by ExecPay. In other words, Ceesay earned more than 28.8% of executives.

ClassificationRankingPercentile
All
10,439
out of 14,666
29th
Division
Manufacturing
4,050
out of 5,768
30th
Major group
Chemicals And Allied Products
1,431
out of 2,074
31st
Industry group
Drugs
1,165
out of 1,730
33rd
Industry
Pharmaceutical Preparations
908
out of 1,329
32nd
Source: SEC filing on April 30, 2018.

Ceesay's colleagues

We found three more compensation records of executives who worked with Abraham Ceesay at scPharmaceuticals in 2017.

2017

John Tucker

scPharmaceuticals

Chief Executive Officer

2017

Troy Ignelzi

scPharmaceuticals

Chief Financial Officer

2017

Pieter Muntendam

scPharmaceuticals

Chief Executive Officer

News

You may also like